KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals Presents KVD900 Data at European Academy of Allergy and Clinical Immunology Jun 4, 2019 KalVista Pharmaceuticals to Present at Jefferies Healthcare Conference May 30, 2019 KalVista Pharmaceuticals Presents KVD900 Data at C1-Inhibitor Deficiency and Angioedema Workshop May 28, 2019 All News
KalVista Pharmaceuticals Presents KVD900 Data at European Academy of Allergy and Clinical Immunology Jun 4, 2019
KalVista Pharmaceuticals Presents KVD900 Data at C1-Inhibitor Deficiency and Angioedema Workshop May 28, 2019
